US4179337A
(en)
|
1973-07-20 |
1979-12-18 |
Davis Frank F |
Non-immunogenic polypeptides
|
JPS54113492A
(en)
|
1978-02-24 |
1979-09-05 |
Sanyo Chem Ind Ltd |
Preparation of glucoprotein derivative
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
US4757006A
(en)
|
1983-10-28 |
1988-07-12 |
Genetics Institute, Inc. |
Human factor VIII:C gene and recombinant methods for production
|
US4970300A
(en)
|
1985-02-01 |
1990-11-13 |
New York University |
Modified factor VIII
|
US5250421A
(en)
|
1986-01-03 |
1993-10-05 |
Genetics Institute, Inc. |
Method for producing factor VIII:C-type proteins
|
US5198349A
(en)
|
1986-01-03 |
1993-03-30 |
Genetics Institute, Inc. |
Method for producing factor VIII:C and analogs
|
JPH0387173A
(ja)
|
1987-09-10 |
1991-04-11 |
Teijin Ltd |
ヒト活性化天然型ファクター8cの製造方法及びそれに用いる形質転換体
|
US5153265A
(en)
|
1988-01-20 |
1992-10-06 |
Cetus Corporation |
Conjugation of polymer to colony stimulating factor-1
|
US4966999A
(en)
|
1988-06-07 |
1990-10-30 |
Cytogen Corporation |
Radiohalogenated compounds for site specific labeling
|
US5122614A
(en)
|
1989-04-19 |
1992-06-16 |
Enzon, Inc. |
Active carbonates of polyalkylene oxides for modification of polypeptides
|
SE465222C5
(sv)
|
1989-12-15 |
1998-02-10 |
Pharmacia & Upjohn Ab |
Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
|
SE466754B
(sv)
|
1990-09-13 |
1992-03-30 |
Berol Nobel Ab |
Saett att kovalent binda biopolymerer till hydrofila ytor
|
CA2073511A1
(en)
|
1990-11-14 |
1992-05-29 |
Matthew R. Callstrom |
Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
|
EP0576589A4
(en)
|
1991-03-18 |
1994-07-27 |
Enzon Inc |
Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
|
US5846951A
(en)
|
1991-06-06 |
1998-12-08 |
The School Of Pharmacy, University Of London |
Pharmaceutical compositions
|
US6037452A
(en)
|
1992-04-10 |
2000-03-14 |
Alpha Therapeutic Corporation |
Poly(alkylene oxide)-Factor VIII or Factor IX conjugate
|
WO1994005332A2
(en)
|
1992-09-01 |
1994-03-17 |
Berlex Laboratories, Inc. |
Glycolation of glycosylated macromolecules
|
US5733873A
(en)
|
1992-10-02 |
1998-03-31 |
Pharmacia & Upjohn Ab |
Composition comprising coagulation factor VIII formulation, process for its preparation and use of a surfactant as stabilizer
|
NZ250375A
(en)
|
1992-12-09 |
1995-07-26 |
Ortho Pharma Corp |
Peg hydrazone and peg oxime linkage forming reagents and protein derivatives
|
US5298643A
(en)
|
1992-12-22 |
1994-03-29 |
Enzon, Inc. |
Aryl imidate activated polyalkylene oxides
|
AU6029594A
(en)
|
1993-01-15 |
1994-08-15 |
Enzon, Inc. |
Factor viii - polymeric conjugates
|
US5621039A
(en)
|
1993-06-08 |
1997-04-15 |
Hallahan; Terrence W. |
Factor IX- polymeric conjugates
|
SE504074C2
(sv)
|
1993-07-05 |
1996-11-04 |
Pharmacia Ab |
Proteinberedning för subkutan, intramuskulär eller intradermal administrering
|
US6011007A
(en)
|
1993-09-17 |
2000-01-04 |
Novo Nordisk A/S |
Acylated insulin
|
WO1995007931A1
(en)
|
1993-09-17 |
1995-03-23 |
Novo Nordisk A/S |
Acylated insulin
|
US6869930B1
(en)
|
1993-09-17 |
2005-03-22 |
Novo Nordisk A/S |
Acylated insulin
|
EP0788375A2
(en)
|
1994-11-09 |
1997-08-13 |
Robin Ewart Offord |
Functionalized polymers for site-specific attachment
|
WO1996040662A2
(en)
|
1995-06-07 |
1996-12-19 |
Cellpro, Incorporated |
Aminooxy-containing linker compounds and their application in conjugates
|
WO1996040731A1
(en)
|
1995-06-07 |
1996-12-19 |
Mount Sinai School Of Medicine Of The City University Of New York |
Pegylated modified proteins
|
SE9503380D0
(sv)
|
1995-09-29 |
1995-09-29 |
Pharmacia Ab |
Protein derivatives
|
US5866538A
(en)
|
1996-06-20 |
1999-02-02 |
Novo Nordisk A/S |
Insulin preparations containing NaCl
|
JP2002505574A
(ja)
|
1997-04-30 |
2002-02-19 |
エンゾン,インコーポレイテッド |
ポリアルキレンオキシド修飾された単鎖ポリペプチド
|
US6183738B1
(en)
|
1997-05-12 |
2001-02-06 |
Phoenix Pharamacologics, Inc. |
Modified arginine deiminase
|
CA2292760A1
(en)
|
1997-06-04 |
1998-12-10 |
Oxford Biomedica (Uk) Limited |
Vector
|
US6531298B2
(en)
|
1997-07-21 |
2003-03-11 |
The University Of North Carolina At Chapel Hill |
Factor IX antihemophilic factor with increased clotting activity
|
WO2001082943A2
(en)
|
2000-05-03 |
2001-11-08 |
Novo Nordisk A/S |
Subcutaneous administration of coagulation factor vii
|
DE59813187D1
(de)
|
1997-12-03 |
2005-12-15 |
Roche Diagnostics Gmbh |
Verfahren zur herstellung von polypeptiden mit geeigneter glykosilierung
|
US5985263A
(en)
|
1997-12-19 |
1999-11-16 |
Enzon, Inc. |
Substantially pure histidine-linked protein polymer conjugates
|
US6596398B1
(en)
|
1998-08-21 |
2003-07-22 |
Atofina Chemicals, Inc. |
Solar control coated glass
|
ES2170042T3
(es)
|
1998-08-28 |
2004-10-01 |
Gryphon Therapeutics, Inc. |
Procedimiento para la preparacion de cadenas de poliamida de longitud precisa y sus conjugados con proteinas.
|
SG110047A1
(en)
|
1998-10-16 |
2005-04-28 |
Biogen Inc |
Polymer conjugates of interferon beta-a1 and uses
|
DE19852729A1
(de)
|
1998-11-16 |
2000-05-18 |
Werner Reutter |
Rekombinante Glycoproteine, Verfahren zu ihrer Herstellung, sie enthaltende Arzneimittel und ihre Verwendung
|
MXPA01008515A
(es)
|
1999-02-22 |
2003-06-06 |
Baxter Int |
Formulaciones novedosas de factor viii libres de albumina.
|
KR20020022691A
(ko)
*
|
1999-06-08 |
2002-03-27 |
와이즈먼 앤드루 |
아미노옥시기를 포함하는 원자가 플랫폼 분자
|
US6531122B1
(en)
|
1999-08-27 |
2003-03-11 |
Maxygen Aps |
Interferon-β variants and conjugates
|
US7230081B1
(en)
|
1999-11-12 |
2007-06-12 |
Maxygen Holdings, Ltd. |
Interferon gamma conjugates
|
US7074878B1
(en)
|
1999-12-10 |
2006-07-11 |
Harris J Milton |
Hydrolytically degradable polymers and hydrogels made therefrom
|
US6413507B1
(en)
|
1999-12-23 |
2002-07-02 |
Shearwater Corporation |
Hydrolytically degradable carbamate derivatives of poly (ethylene glycol)
|
RU2278123C2
(ru)
|
2000-02-11 |
2006-06-20 |
Максиджен Холдингз Лтд. |
Молекулы, подобные фактору vii или viia
|
JP4455802B2
(ja)
|
2000-05-03 |
2010-04-21 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
ヒト第vii凝固因子変異型
|
AU2001268228A1
(en)
|
2000-06-08 |
2001-12-17 |
La Jolla Pharmaceutical Company |
Multivalent platform molecules comprising high molecular weight polyethylene oxide
|
US6423826B1
(en)
|
2000-06-30 |
2002-07-23 |
Regents Of The University Of Minnesota |
High molecular weight derivatives of vitamin K-dependent polypeptides
|
US7118737B2
(en)
|
2000-09-08 |
2006-10-10 |
Amylin Pharmaceuticals, Inc. |
Polymer-modified synthetic proteins
|
AU2001287550B2
(en)
|
2000-09-13 |
2007-03-22 |
Novo Nordisk Health Care Ag |
Human coagulation factor VII variants
|
KR100880624B1
(ko)
|
2000-10-02 |
2009-01-30 |
노보 노르디스크 헬스 케어 악티엔게젤샤프트 |
비타민 k-의존 단백질의 생산 방법
|
GB0103877D0
(en)
*
|
2001-02-16 |
2001-04-04 |
King S College London |
Novel Drug Delivery system
|
HUP0401124A3
(en)
|
2001-03-22 |
2006-01-30 |
Novo Nordisk Healthcare Ag |
Coagulation factor vii derivatives
|
US6913915B2
(en)
|
2001-08-02 |
2005-07-05 |
Phoenix Pharmacologics, Inc. |
PEG-modified uricase
|
US6770625B2
(en)
*
|
2001-09-07 |
2004-08-03 |
Nobex Corporation |
Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
|
US7795210B2
(en)
|
2001-10-10 |
2010-09-14 |
Novo Nordisk A/S |
Protein remodeling methods and proteins/peptides produced by the methods
|
PT2279753E
(pt)
|
2001-10-10 |
2016-01-15 |
Novo Nordisk As |
Remodelação e glicoconjugação de péptidos
|
US7265084B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
AU2002352524B2
(en)
|
2001-11-07 |
2007-10-04 |
Nektar Therapeutics |
Branched polymers and their conjugates
|
EP1461445B1
(en)
|
2001-11-28 |
2008-08-20 |
Neose Technologies, Inc. |
Glycoprotein remodeling using endoglycanases
|
CA2468230A1
(en)
|
2001-11-28 |
2003-06-05 |
Neose Technologies, Inc. |
Glycopeptide remodeling using amidases
|
UA86744C2
(en)
|
2002-06-21 |
2009-05-25 |
Ново Нордиск Хэлс Кеа Аг |
Pegylated factor vii glycoforms
|
US7122189B2
(en)
|
2002-08-13 |
2006-10-17 |
Enzon, Inc. |
Releasable polymeric conjugates based on aliphatic biodegradable linkers
|
US7087229B2
(en)
|
2003-05-30 |
2006-08-08 |
Enzon Pharmaceuticals, Inc. |
Releasable polymeric conjugates based on aliphatic biodegradable linkers
|
EP1681303B1
(en)
|
2002-09-11 |
2013-09-04 |
Fresenius Kabi Deutschland GmbH |
HASylated polypeptides, especially HASylated erythropoietin
|
EP1400533A1
(en)
|
2002-09-11 |
2004-03-24 |
Fresenius Kabi Deutschland GmbH |
HASylated polypeptides, especially HASylated erythropoietin
|
BR0314227A
(pt)
|
2002-09-11 |
2005-10-25 |
Fresenius Kabi De Gmbh |
Derivados de amido de hidroxialquila
|
US20040062748A1
(en)
|
2002-09-30 |
2004-04-01 |
Mountain View Pharmaceuticals, Inc. |
Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
|
MXPA05007151A
(es)
|
2002-12-31 |
2005-09-21 |
Nektar Therapeutics Al Corp |
Polimeros terminados en maleimida hidroliticamente estables.
|
JP4490369B2
(ja)
|
2002-12-31 |
2010-06-23 |
ネクター セラピューティクス アラバマ,コーポレイション |
マレアミド酸ポリマー誘導体及びこれらの生物学的複合体
|
MXPA05009169A
(es)
|
2003-02-26 |
2005-11-17 |
Nektar Therapeutics Al Corp |
Conjugados de polimero-porcion del factor viii.
|
US7623892B2
(en)
|
2003-04-02 |
2009-11-24 |
Palm, Inc. |
System and method for enabling a person to switch use of computing devices
|
EP1620118B1
(en)
|
2003-04-08 |
2014-06-18 |
Yeda Research And Development Co., Ltd. |
Reversible pegylated drugs
|
CA2522345A1
(en)
|
2003-04-09 |
2004-11-18 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
CN1832762B
(zh)
*
|
2003-08-08 |
2012-09-05 |
弗雷泽纽斯卡比德国有限公司 |
羟烷基淀粉与g-csf的偶联物
|
BRPI0412671A
(pt)
|
2003-08-08 |
2006-10-03 |
Fresenius Kabi De Gmbh |
conjugados de um polìmero e uma proteìna ligados por um grupo de ligação de oxima
|
WO2005014655A2
(en)
|
2003-08-08 |
2005-02-17 |
Fresenius Kabi Deutschland Gmbh |
Conjugates of hydroxyalkyl starch and a protein
|
JP2007501812A
(ja)
|
2003-08-08 |
2007-02-01 |
ノボ ノルディスク アクティーゼルスカブ |
ペプチドのための結合剤として新しい構造上十分に定義された枝分れしたポリマーの合成および適用
|
KR101113726B1
(ko)
|
2003-08-12 |
2012-02-27 |
리폭센 테크놀로지즈 리미티드 |
단백질 유도 및 컨쥬게이션용 시알산 유도체
|
US8633157B2
(en)
|
2003-11-24 |
2014-01-21 |
Novo Nordisk A/S |
Glycopegylated erythropoietin
|
JP4657219B2
(ja)
|
2003-12-03 |
2011-03-23 |
バイオジェネリックス アーゲー |
GlycoPEG化された顆粒球コロニー刺激因子
|
MXPA06006023A
(es)
|
2003-12-03 |
2006-08-23 |
Neose Technologies Inc |
Factor ix glicopegilado.
|
US20060040856A1
(en)
|
2003-12-03 |
2006-02-23 |
Neose Technologies, Inc. |
Glycopegylated factor IX
|
CA2552892C
(en)
|
2004-01-08 |
2014-08-05 |
Neose Technologies, Inc. |
O-linked glycosylation of peptides
|
EP1758608A2
(en)
|
2004-03-11 |
2007-03-07 |
Fresenius Kabi Deutschland GmbH |
Conjugates of hydroxyethyl starch and erythropoietin
|
GB0412181D0
(en)
*
|
2004-06-01 |
2004-06-30 |
Celltech R&D Ltd |
Biological products
|
US20090292110A1
(en)
|
2004-07-23 |
2009-11-26 |
Defrees Shawn |
Enzymatic modification of glycopeptides
|
WO2006013202A2
(en)
|
2004-08-02 |
2006-02-09 |
Novo Nordisk Health Care Ag |
Conjugation of fvii
|
ES2593318T3
(es)
|
2004-08-12 |
2016-12-07 |
Lipoxen Technologies Limited |
Derivados de ácido siálico
|
US8268967B2
(en)
|
2004-09-10 |
2012-09-18 |
Novo Nordisk A/S |
Glycopegylated interferon α
|
KR20120136413A
(ko)
|
2004-11-12 |
2012-12-18 |
바이엘 헬스케어 엘엘씨 |
Fviii의 부위 지향 변형
|
US7385028B2
(en)
|
2004-12-22 |
2008-06-10 |
Ambrx, Inc |
Derivatization of non-natural amino acids and polypeptides
|
WO2006071801A2
(en)
|
2004-12-27 |
2006-07-06 |
Baxter International Inc |
Polymer-von willebrand factor-conjugates
|
JP2008526864A
(ja)
|
2005-01-06 |
2008-07-24 |
ネオス テクノロジーズ インコーポレイテッド |
糖断片を用いる糖結合
|
JP2008529978A
(ja)
*
|
2005-02-08 |
2008-08-07 |
ザ カウンシル オブ ザ クイーンズランド インスティテュート オブ メディカル リサーチ |
免疫原性分子
|
EP1891231A4
(en)
|
2005-05-25 |
2011-06-22 |
Novo Nordisk As |
GLYCOPEGYLATED FACTOR IX
|
AU2006259225B2
(en)
|
2005-06-16 |
2012-05-31 |
Nektar Therapeutics |
Conjugates having a degradable linkage and polymeric reagents useful in preparing such conjugates
|
EP1893632B1
(en)
|
2005-06-17 |
2015-08-12 |
Novo Nordisk Health Care AG |
Selective reduction and derivatization of engineered factor vii proteins comprising at least one non-native cysteine
|
US20090017007A1
(en)
|
2005-08-26 |
2009-01-15 |
Maxygen Holdings Ltd. |
Liquid factor vii composition
|
RU2008105545A
(ru)
*
|
2005-08-30 |
2009-10-10 |
Ново Нордиск Хелс Кеа Аг (Ch) |
Жидкие препараты пэгилированного гормона роста
|
WO2007076062A2
(en)
|
2005-12-21 |
2007-07-05 |
Wyeth |
Protein formulations with reduced viscosity and uses thereof
|
JP2009523815A
(ja)
*
|
2006-01-19 |
2009-06-25 |
アンブルックス,インコーポレイテッド |
免疫原性が調節された非天然アミノ酸ポリペプチド
|
US7645860B2
(en)
|
2006-03-31 |
2010-01-12 |
Baxter Healthcare S.A. |
Factor VIII polymer conjugates
|
BRPI0708832A2
(pt)
|
2006-03-31 |
2011-06-14 |
Baxter Int |
construÇço proteinÁcea
|
US20090285780A1
(en)
|
2006-05-24 |
2009-11-19 |
Chyi Lee |
Peg linker compounds and biologically active conjugates thereof
|
US7939632B2
(en)
|
2006-06-14 |
2011-05-10 |
Csl Behring Gmbh |
Proteolytically cleavable fusion proteins with high molar specific activity
|
SI2049692T1
(sl)
|
2006-07-13 |
2016-04-29 |
Serum Institute Of India Ltd |
Postopek za pripravo polisialične kisline visoke čistosti
|
ES2531934T3
(es)
|
2006-09-01 |
2015-03-20 |
Novo Nordisk Health Care Ag |
Glicoproteínas modificadas
|
EP2054521A4
(en)
|
2006-10-03 |
2012-12-19 |
Novo Nordisk As |
METHODS OF PURIFYING CONJUGATES OF POLYPEPTIDES
|
WO2008058547A2
(en)
*
|
2006-11-17 |
2008-05-22 |
Nya Hamlet Pharma Ab |
Alpha-lactalbumin composition
|
US8637007B2
(en)
|
2006-12-15 |
2014-01-28 |
Baxter International Inc. |
Factor VIIa-polysialic acid conjugate having prolonged in vivo half-life
|
MX2009007001A
(es)
|
2006-12-28 |
2009-07-10 |
Ambrx Inc |
Aminoacidos y polipeptidos fenazina y quinoxalina sustituidos.
|
EP2099475B1
(en)
|
2007-01-03 |
2016-08-24 |
Novo Nordisk Health Care AG |
Subcutaneous administration of coagulation factor viia-related polypeptides
|
WO2008119815A1
(en)
|
2007-04-02 |
2008-10-09 |
Novo Nordisk A/S |
Subcutaneous administration of coagulation factor ix
|
MX2009013682A
(es)
|
2007-06-26 |
2010-08-31 |
Baxter Int |
Enlazador de fmoc polimerico hidrolizable.
|
WO2009006620A1
(en)
|
2007-07-03 |
2009-01-08 |
Children's Hospital & Research Center At Oakland |
Oligosialic acid derivatives, methods of manufacture, and immunological uses
|
EP2209494B1
(en)
|
2007-10-09 |
2016-07-20 |
Polytherics Limited |
Novel conjugated proteins and peptides
|
EP2070951A1
(en)
|
2007-12-14 |
2009-06-17 |
Fresenius Kabi Deutschland GmbH |
Method for producing a hydroxyalkyl starch derivatives with two linkers
|
EP2242505A4
(en)
|
2008-01-08 |
2012-03-07 |
Biogenerix Ag |
GLYCOCONJUGATION OF POLYPEPTIDES USING OLIGOSACCHARYLTRANSFERASES
|
AU2009219232B2
(en)
|
2008-02-27 |
2014-02-27 |
Novo Nordisk A/S |
Conjugated Factor VIII molecules
|
CN102046205A
(zh)
|
2008-04-24 |
2011-05-04 |
凯尔特药物Peg有限公司 |
具有延长的半衰期的因子ix缀合物
|
EP2285412A1
(en)
|
2008-05-23 |
2011-02-23 |
Novo Nordisk Health Care AG |
Formulations of peg-functionalised serine proteases with high concentrations of an aromatic preservative
|
CN102083459A
(zh)
|
2008-05-23 |
2011-06-01 |
诺沃-诺迪斯克保健股份有限公司 |
包括含有peg化的gla-结构域的蛋白质的低粘度组合物
|
JP5674650B2
(ja)
|
2008-06-04 |
2015-02-25 |
バイエル・ヘルスケア・エルエルシー |
フォン・ヴィレブランド病の処置のためのfviii変異タンパク質
|
JP5622117B2
(ja)
|
2008-07-21 |
2014-11-12 |
ポリテリクスリミテッド |
生体分子を接合するための新規な試薬及び方法
|
US20120027743A1
(en)
|
2008-11-03 |
2012-02-02 |
Bayer Healthcare Llc |
Method for the Treatment of Hemophilia
|
CA2748662A1
(en)
|
2009-01-19 |
2010-07-22 |
Bayer Healthcare Llc |
Protein conjugate having an endopeptidase-cleavable bioprotective moiety
|
ES2401965T3
(es)
|
2009-02-19 |
2013-04-25 |
Novo Nordisk A/S |
Modificación de Factor VIII
|
EP2403538B1
(en)
|
2009-03-04 |
2017-10-04 |
Polytherics Limited |
Conjugated proteins and peptides
|
WO2010120365A2
(en)
|
2009-04-16 |
2010-10-21 |
Wu Nian |
Protein-carrier conjugates
|
WO2010140148A1
(en)
|
2009-06-01 |
2010-12-09 |
Yeda Research And Development Co . Ltd |
Prodrugs containing albumin binding probe
|
PE20121643A1
(es)
|
2009-07-31 |
2012-11-25 |
Bayer Healthcare Llc |
Polipeptidos del factor ix modificados y usos de los mismos
|
DE102009028526A1
(de)
|
2009-08-13 |
2011-02-24 |
Leibniz-Institut Für Polymerforschung Dresden E.V. |
Verfahren zur Modifikation und Funktionalisierung von Sacchariden
|
EP2480578A4
(en)
|
2009-09-25 |
2013-04-17 |
Vybion Inc |
MODIFICATION OF POLYPEPTIDE
|
WO2011064247A1
(en)
|
2009-11-24 |
2011-06-03 |
Novo Nordisk Health Care Ag |
Method of purifying pegylated proteins
|
CN105524164A
(zh)
|
2010-02-16 |
2016-04-27 |
诺沃—诺迪斯克有限公司 |
具有降低的vwf结合的因子viii分子
|
EP2536752B1
(en)
|
2010-02-16 |
2015-04-08 |
Novo Nordisk A/S |
Modified recombinant Factor VIII
|
GB201007356D0
(en)
|
2010-04-30 |
2010-06-16 |
Leverton Licence Holdings Ltd |
Conjugated factor VIIa
|
GB201007357D0
(en)
|
2010-04-30 |
2010-06-16 |
Leverton Licence Holdings Ltd |
Conjugated factor VIII
|
CN108079312A
(zh)
|
2010-07-30 |
2018-05-29 |
百深有限责任公司 |
用于肟键联的亲核性催化剂
|
WO2012068134A1
(en)
|
2010-11-15 |
2012-05-24 |
Biogen Idec Inc. |
Enrichment and concentration of select product isoforms by overloaded bind and elute chromatography
|
KR101829603B1
(ko)
|
2011-07-08 |
2018-02-19 |
바이오버라티브 테라퓨틱스 인크. |
Viii 인자 키메라 및 하이브리드 폴리펩타이드, 그리고 이들의 사용 방법
|